跳至主要内容
临床试验/NCT02319876
NCT02319876Unknown不适用

Expression and the Clinical Significance of TIM-3 on Lymphocytes During Sepsis

Changhai Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2014年2月最近更新:
适应症

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
TIM-3 expression on CD4+, CD8+ T cells and CD14+ monocytes

研究概览

简要总结

The current project was designed to examine the express TIM-3 on lymphocytes and monocytes and its role in immunosuppression during sepsis.

详细描述

Immunosuppression is the leading cause of death in septic patients.Lymphocyte apoptosis has been recognized as an important step in the pathogenesis of sepsis. Previous studies indicated that T cell immunoglobulin and mucin protein 3 (TIM-3) is a type I cell surface protein and was identified as a marker of lymphocyte dysfunction. The current project was designed to examine the express TIM-3 on lymphocytes and monocytes and its further role in immunosuppression during sepsis.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with severe sepsis
  • patients undergo invasive spine surgery
  • healthy volunteers

排除标准

  • patients with immunodeficient diseases
  • patients who accept glucocorticoid or immunosuppressant
  • patients with an age older than 18 years
  • patients providing the informed consent

结局指标

主要结局

TIM-3 expression on CD4+, CD8+ T cells and CD14+ monocytes

时间窗: within 24h after recruitment

TIM-3 level on T cells was compared between different populations.

次要结局

  • 28-day mortality(28 days after diagnosis of sepsis)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiaoming Deng

professor and chief

Changhai Hospital

研究点 (1)

Loading locations...

相似试验